Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria
Clinical trial NCT04513548 · TERMINATED
Trial details
- NCT number
- NCT04513548
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2022-07-19
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.